SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-029551
Filing Date
2013-05-15
Accepted
2013-05-15 16:31:07
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v342056_10q.htm 10-Q 254701
2 EXHIBIT 31.1 v342056_ex31-1.htm EX-31.1 9374
3 EXHIBIT 31.2 v342056_ex31-2.htm EX-31.2 9427
4 EXHIBIT 32.1 v342056_ex32-1.htm EX-32.1 4649
  Complete submission text file 0001144204-13-029551.txt   2674725

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nvlt-20130331.xml EX-101.INS 277749
6 XBRL TAXONOMY EXTENSION SCHEMA nvlt-20130331.xsd EX-101.SCH 37449
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvlt-20130331_cal.xml EX-101.CAL 35827
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvlt-20130331_def.xml EX-101.DEF 172433
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvlt-20130331_lab.xml EX-101.LAB 312381
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvlt-20130331_pre.xml EX-101.PRE 206077
Mailing Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458
Business Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458 617-244-1616
NOVELOS THERAPEUTICS, INC. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-119366 | Film No.: 13847637
SIC: 2834 Pharmaceutical Preparations